Sri Rejeki Isman Tbk PT
IDX:SRIL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sri Rejeki Isman Tbk PT
IDX:SRIL
|
ID |
|
Guangdong Cellwise Microelectronics Co Ltd
SSE:688325
|
CN |
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
TW |
|
Amigo Holdings PLC
LSE:AMGO
|
UK |
|
Kidsland International Holdings Ltd
HKEX:2122
|
CN |
|
Compania Cervecerias Unidas SA
NYSE:CCU
|
CL |
|
Zhejiang Orient Gene Biotech Co Ltd
SSE:688298
|
CN |
|
J
|
JSL Industries Ltd
BSE:504080
|
IN |
|
H
|
Hangzhou Sf Intra-City Industrial Co Ltd
HKEX:9699
|
CN |
|
Kuangli Bio Tech Holdings Co Ltd
TWSE:6431
|
TW |
|
S
|
Synthiko Foils Ltd
BSE:513307
|
IN |
|
M
|
Malam Team Ltd
TASE:MLTM
|
IL |
|
Daiwa House Industry Co Ltd
OTC:DWAHY
|
JP |
|
N
|
Neways Electronics International NV
LSE:0NEB
|
NL |
|
Z
|
ZhongWang Fabric Co Ltd
SSE:605003
|
CN |
|
V
|
Vincit Oyj
OMXH:VINCIT
|
FI |
|
Airgain Inc
NASDAQ:AIRG
|
US |
|
C
|
CaoCao Inc
HKEX:2643
|
CN |
|
Rheinmetall AG
XETRA:RHM
|
DE |
|
RioCan Real Estate Investment Trust
TSX:REI.UN
|
CA |
|
E
|
Erin Energy Corp
OTC:ERINQ
|
US |
Balance Sheet
Balance Sheet Decomposition
Sri Rejeki Isman Tbk PT
Sri Rejeki Isman Tbk PT
Balance Sheet
Sri Rejeki Isman Tbk PT
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
10
|
6
|
6
|
76
|
67
|
98
|
117
|
9
|
16
|
2
|
|
| Cash |
10
|
6
|
6
|
76
|
67
|
98
|
117
|
9
|
16
|
2
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
72
|
71
|
54
|
51
|
61
|
71
|
71
|
0
|
0
|
0
|
|
| Total Receivables |
129
|
102
|
150
|
189
|
196
|
265
|
350
|
82
|
44
|
53
|
|
| Accounts Receivables |
129
|
102
|
150
|
189
|
196
|
265
|
350
|
82
|
44
|
53
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
110
|
136
|
148
|
266
|
332
|
361
|
495
|
380
|
150
|
72
|
|
| Other Current Assets |
6
|
8
|
20
|
63
|
50
|
100
|
119
|
119
|
63
|
70
|
|
| Total Current Assets |
326
|
323
|
378
|
645
|
706
|
895
|
1 151
|
589
|
273
|
197
|
|
| PP&E Net |
323
|
441
|
519
|
547
|
654
|
654
|
691
|
546
|
486
|
451
|
|
| PP&E Gross |
323
|
441
|
519
|
547
|
654
|
654
|
691
|
546
|
486
|
451
|
|
| Accumulated Depreciation |
118
|
138
|
158
|
181
|
399
|
438
|
507
|
667
|
727
|
760
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
43
|
19
|
50
|
1
|
4
|
11
|
10
|
99
|
5
|
1
|
|
| Total Assets |
699
N/A
|
783
+12%
|
947
+21%
|
1 193
+26%
|
1 364
+14%
|
1 559
+14%
|
1 852
+19%
|
1 234
-33%
|
765
-38%
|
649
-15%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
19
|
11
|
6
|
55
|
59
|
35
|
37
|
56
|
28
|
32
|
|
| Accrued Liabilities |
8
|
7
|
6
|
8
|
11
|
10
|
17
|
81
|
15
|
17
|
|
| Short-Term Debt |
32
|
38
|
73
|
102
|
123
|
68
|
278
|
973
|
9
|
11
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
30
|
3
|
11
|
48
|
43
|
428
|
16
|
13
|
|
| Other Current Liabilities |
6
|
11
|
8
|
7
|
25
|
22
|
24
|
34
|
38
|
41
|
|
| Total Current Liabilities |
64
|
67
|
124
|
175
|
229
|
183
|
398
|
1 571
|
106
|
113
|
|
| Long-Term Debt |
380
|
413
|
465
|
549
|
587
|
739
|
729
|
18
|
1 336
|
1 277
|
|
| Deferred Income Tax |
14
|
16
|
15
|
9
|
10
|
11
|
13
|
10
|
16
|
35
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
8
|
10
|
13
|
18
|
22
|
34
|
39
|
24
|
88
|
179
|
|
| Total Liabilities |
467
N/A
|
507
+8%
|
616
+22%
|
751
+22%
|
848
+13%
|
967
+14%
|
1 180
+22%
|
1 623
+38%
|
1 546
-5%
|
1 604
+4%
|
|
| Equity | |||||||||||
| Common Stock |
152
|
152
|
152
|
167
|
167
|
167
|
167
|
167
|
167
|
167
|
|
| Retained Earnings |
75
|
122
|
178
|
242
|
314
|
397
|
480
|
592
|
987
|
1 162
|
|
| Additional Paid In Capital |
10
|
10
|
10
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
|
| Other Equity |
6
|
8
|
9
|
12
|
10
|
17
|
19
|
10
|
6
|
5
|
|
| Total Equity |
231
N/A
|
277
+20%
|
331
+20%
|
442
+34%
|
516
+17%
|
593
+15%
|
672
+13%
|
389
N/A
|
781
-101%
|
955
-22%
|
|
| Total Liabilities & Equity |
699
N/A
|
783
+12%
|
947
+21%
|
1 193
+26%
|
1 364
+14%
|
1 559
+14%
|
1 852
+19%
|
1 234
-33%
|
765
-38%
|
649
-15%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
18 593
|
18 593
|
18 593
|
18 593
|
20 452
|
20 452
|
20 452
|
20 452
|
20 452
|
20 452
|
|